Eucrates Biomedical Acquisition Corp.

What is Eucrates Biomedical Acquisition Corp. (EUCR) stock price today?

As of Apr 26, 2023, 7:14 PM UTC, Eucrates Biomedical Acquisition Corp. (EUCR) stock is trading at $10.04. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date EUCR stock quotes for informed trading decisions.

What is Eucrates Biomedical Acquisition Corp.'s market capitalization?

Eucrates Biomedical Acquisition Corp. (EUCR) has a market capitalization of approximately $42.2M. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare Eucrates Biomedical Acquisition Corp.'s size relative to other companies in the USD market. The market cap figure updates automatically as the EUCR stock price changes.

What is the 52-week range for Eucrates Biomedical Acquisition Corp. stock?

Eucrates Biomedical Acquisition Corp. (EUCR) stock has traded in a 52-week range of $9.87 — $10.25. The 52-week range shows the highest and lowest prices at which EUCR traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current Eucrates Biomedical Acquisition Corp. stock price to this range provides context for recent price action.

How much trading volume does Eucrates Biomedical Acquisition Corp. stock have?

Eucrates Biomedical Acquisition Corp. (EUCR) stock recently traded approximately 12.7K shares. Trading volume indicates market liquidity and investor interest in EUCR. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting Eucrates Biomedical Acquisition Corp. stock.

Does Eucrates Biomedical Acquisition Corp. pay dividends to shareholders?

Yes, Eucrates Biomedical Acquisition Corp. (EUCR) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate Eucrates Biomedical Acquisition Corp. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is Eucrates Biomedical Acquisition Corp.'s intraday price range?

Today, Eucrates Biomedical Acquisition Corp. (EUCR) stock has traded in a range of $10.02 — $10.04. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring EUCR's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get Eucrates Biomedical Acquisition Corp. stock data?

AlphaPilot sources real-time EUCR stock quotes, fundamental financial data, and historical price charts for Eucrates Biomedical Acquisition Corp. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The Eucrates Biomedical Acquisition Corp. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of EUCR stock performance.